A 38-year-old woman with gallstones presents with acute onset epigastric pain, nausea, and vomiting for 48 hours. On examination, she is afebrile, BP 110/70, HR 92/min, with mild epigastric tenderness but no peritoneal signs. Serum amylase is 680 U/L, lipase 1520 U/L, total bilirubin 2.8 mg/dL (direct 2.1 mg/dL), ALT 280 U/L, AST 240 U/L. Ultrasound shows gallstones, a dilated common bile duct (8 mm), and no free fluid. Contrast-enhanced CT abdomen shows mild pancreatic edema without necrosis. She is started on IV fluids, antibiotics, and analgesia. Over the next 18 hours, her pain improves and she tolerates oral intake. Amylase and lipase levels are trending downward. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has **mild biliary pancreatitis** (gallstone-induced acute pancreatitis) with: - Mild elevation of pancreatic enzymes (amylase 680, lipase 1520) - Mild pancreatic edema on CT (no necrosis) - Evidence of biliary obstruction (elevated bilirubin, dilated CBD, elevated transaminases) - **Rapid clinical improvement** within 18 hours (pain improving, tolerating oral intake, enzymes trending down) - No fever, no peritoneal signs, hemodynamically stable ## Management Algorithm for Biliary Pancreatitis ```mermaid flowchart TD A[Acute Biliary Pancreatitis]:::outcome --> B{Severity?}:::decision B -->|Mild<br/>No necrosis| C{Persistent cholangitis<br/>or biliary obstruction?}:::decision B -->|Moderate/Severe<br/>Necrosis present| D[ERCP within 24-48 hrs<br/>if cholangitis/obstruction]:::action C -->|Yes, ongoing obstruction| E[ERCP with sphincterotomy<br/>within 24-48 hrs]:::action C -->|No, improving clinically| F[Elective cholecystectomy<br/>within 48-72 hrs]:::action F --> G[Definitive treatment<br/>prevents recurrence]:::outcome E --> H[Cholecystectomy after<br/>acute phase resolves]:::action ``` ## Key Point: **In mild biliary pancreatitis with clinical improvement and no persistent cholangitis, elective laparoscopic cholecystectomy within 48–72 hours of admission is the preferred approach.** This prevents recurrent pancreatitis (30–50% recurrence rate if gallbladder left in situ) and is safer than ERCP in uncomplicated cases. ## High-Yield Facts: | Feature | Mild Biliary Pancreatitis | Severe Biliary Pancreatitis with Cholangitis | |---------|---------------------------|-----------------------------------------------| | **ERCP timing** | Not routinely indicated if improving | Within 24–48 hours | | **Cholecystectomy timing** | Within 48–72 hours of admission | After acute phase (1–2 weeks) | | **Indication for ERCP** | Persistent obstruction, fever, jaundice | Fever + jaundice + dilated CBD | | **Recurrence risk** | 30–50% if gallbladder retained | Prevented by cholecystectomy | ## Clinical Pearl: The **"same-admission cholecystectomy"** approach (within 48–72 hours) for mild biliary pancreatitis reduces hospital readmissions, prevents recurrent pancreatitis, and is cost-effective. ERCP is reserved for **persistent cholangitis** or **ongoing biliary obstruction**, not routine mild pancreatitis. ## Mnemonic: MILD Biliary Pancreatitis Management - **M** — **Mild** pancreatitis (no necrosis, rapid improvement) - **I** — **Improving** clinically (pain down, tolerating diet, enzymes trending down) - **L** — **Laparoscopic cholecystectomy** within 48–72 hours - **D** — **Definitive** treatment (prevents recurrence) ## Why NOT ERCP here? ERCP is indicated for **persistent cholangitis** (fever + jaundice + dilated CBD with clinical deterioration) or **ongoing biliary obstruction**. This patient is improving clinically, afebrile, and has no signs of active cholangitis. ERCP in uncomplicated mild pancreatitis increases morbidity (post-ERCP pancreatitis ~5–7%) without benefit. [cite:Harrison 21e Ch 347; Surgical Care Improvement Project guidelines]